Table 1 Baseline patient characteristics
From: Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignancies
Patient Characteristic | Number of Patients (%) |
|---|---|
Male:Female Ratio | 16:8 |
Average Age (range) years | 62 (26-79) |
Primary Site | |
Parotid | 17 (71%) |
Submandibular | 3 (13%) |
Minor - Base of Tongue | 2 (8%) |
Minor - Sphenoid Sinus | 1 (4%) |
Minor - Ethmoid Sinus | 1 (4%) |
Histology | |
Adenoid Cystic Carcinoma | 5 (21%) |
Mucoepidermoid Carcinoma | 5 (21%) |
Adenocarcinoma | 3 (13%) |
Squamous Cell Carcinoma | 3 (13%) |
Poorly Differentiated Carcinoma | 3 (13%) |
Carcinoma Ex-pleomorphic Adenoma | 2 (8%) |
Myoepithelial Carcinoma | 1 (4%) |
Salivary Duct Carcinoma | 1 (4%) |
Anaplastic Carcinoma | 1 (4%) |
T-Stage | |
1 | 1 (4%) |
2 | 8 (33%) |
3 | 6 (25%) |
4a | 7 (29%) |
4b | 2 (8%) |
N-Stage | |
0 | 6 (25%) |
1 | 3 (13%) |
2a | 0 |
2b | 14 (58%) |
2c | 1 (4%) |
3 | 0 |
Stage | |
II | 1 (4%) |
III | 2 (8%) |
IVA | 19 (79%) |
IVB | 2 (8%) |